Screening of potential molecular markers in cervical cancer cells by ultra-high-speed cell selection platform combined with cDNA microarray technology

Chen Hongxiang

您当前的位置：

首页 >

文章列表页 >

Screening of potential molecular markers in cervical cancer cells by ultra-high-speed cell selection platform combined with cDNA microarray technology

更新时间：2023-04-16

- Screening of potential molecular markers in cervical cancer cells by ultra-high-speed cell selection platform combined with cDNA microarray technology
- Journal of Chongqing Medical University Vol. 48, Issue 1, Pages: 54-60(2023)
- 作者机构：
  
  新疆维吾尔自治区人民医院妇科,乌鲁木齐,830001
- 作者简介：
- 基金信息：
- DOI：
  CLC： R737.3
- Revised：2020-07-27，
  
  Accepted：11 August 2020，
  
  Published：2023
- 稿件说明：
移动端阅览
Chen Hongxiang. Screening of potential molecular markers in cervical cancer cells by ultra-high-speed cell selection platform combined with cDNA microarray technology[J]. Journal of chongqing medical university, 2023, 48(1): 54-60.
DOI：

Chen Hongxiang. Screening of potential molecular markers in cervical cancer cells by ultra-high-speed cell selection platform combined with cDNA microarray technology[J]. Journal of chongqing medical university, 2023, 48(1): 54-60. DOI：

摘要

目的：通过超高速细胞分选平台结合cDNA microarray技术，筛查宫颈癌细胞可能潜在的分子标志物。方法：采用MoFlo XDP型超高速细胞分选平台纯化细胞膜表面表达CD38和不表达CD38的宫颈癌细胞，利用RNAlater技术得到cDNA microarray实验所需RNA，然后进行基因芯片分析。结果：利用MoFlo XDP型超高速细胞分选平台可以获得纯度为99.0%以上的CD38阳性表达宫颈癌细胞。结论： cDNA microarray分析发现了RORA、PLIN4、AUTS2、IFITM1等宫颈癌细胞潜在分子标志物，为宫颈癌研究提供了新的技术方法。

Abstract

Objective: To screen potential molecular markers of cervical cancer cells by ultra-high speed cell sorting platform combined with cDNA microarray technology. Methods: In this paper

the MoFlo XDP-type ultra-high-speed cell selection platform was used to purify cervical cancer cells expressing CD38 and not expressing CD38 on the cell membrane surface. RNAlater technology was used to obtain the RNA required for cDNA microarray experiments

and then by gene chip analysis was made. Results: The MoFlo XDP-type ultra-high-speed cell selection platform can be used to obtain cervical cancer cells with a CD38-positive expression of 99.0% purity. Conclusion: Through the analysis of cDNA microarray

potential molecular markers of cervical cancer cells such as RORA

PLIN4

AUTS2

and IFITM1 have been found

which provides a new technical method for the research of cervical cancer.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Feasibility of an in vitro phantom in high-resolution magnetic resonance imaging of endovaginal coil

Association between M1 macrophage polarization and nonalcoholic fatty liver disease induced by high-fat diet

Mechanism of the splicing factor 3B subunit 1/forkhead box protein M1 signaling pathway regulating cell cycle and intervening against the progression of cervical cancer

Cervical cancer screening system TruScreen with graph neural network-based classification versus HPV DNA quantification in high-risk HPV-positive patients

Research progress on artificial intelligence in screening and precise diagnosis and treatment of cervical cancer

Related Author

Zhang Ke

Tang Mingmei

Yu Bin

Liu Hui

Pan Yuanrui

Lü Fajin

Liu Hua

Meng Qi

Related Institution

Department of Radiology，The First Affiliated Hospital of Chongqing Medical University

State Key Laboratory of Ultrasound in Medicine and Engineering，College of Biomedical Engineering，Chongqing Medical University

Department of Endocrinology，First Affiliated Hospital of Xinjiang Medical University，State Key Laboratory of Pathogenesis，Prevention and Treatment of High Incidence Diseases in Central Asia

Department of Gynecology，Minda Hospital Affiliated to Hubei University for Nationalities

Department of Clinical Laboratory， Qianjiang Hospital，Chongqing University

⁰